JAMPRO
30.9.2021 21:32:09 CEST | Business Wire | Press release
The Jamaica Promotions Corporation (JAMPRO) will be staging Explore: Do Business Jamaica Virtual Investment Conference (DBJVIC) from November 17 – 18, 2021 to introduce local and international investors to business opportunities in the island’s growing industries.
The event will showcase emerging projects and new developments in Agribusiness, Outsourcing, Manufacturing, Energy, Tourism, and the Creative Industries through over 30 panels, interviews and discussions with government and business leaders. The investment conference aims to foster business and stakeholder relationships and will shed light on Jamaica’s COVID-19 economic recovery efforts.
The conference will be staged concurrently via two platforms; one is a virtual interactive business event portal that will facilitate a real-time engagement experience and B2B meetings, the second is a live stream event via social media that will accommodate and drive increased awareness of Jamaica’s economic progress. This format will help JAMPRO to engage attendees including current and potential investors, JAMPRO clients, private and public sector stakeholders, and diplomatic missions.
JAMPRO anticipates extensive global participation based on the planned international promotions which will ensure the leveraging of the virtual B2B meeting platform by potential investors.
New opportunity to do business
Speaking on the event, Jamaica’s Minister of Industry, Investment, and Commerce, The Honourable Audley Shaw, CD, MP., noted that the virtual investment conference has presented a new opportunity for the government to amplify the promotion of Jamaica’s business opportunities.
He explained, “This virtual conference will allow us to reach and directly engage investors across the globe who are interested in doing business with Jamaica but need further market intelligence and guidance on the potential that is available in the island’s sectors. From our perspective, it is the right time to host this global event, as persons are seeking new ventures as the world slowly returns to normality .”
Diane Edwards, President of JAMPRO, echoed the Minister’s statements, and expressed confidence in the conference’s ability to deliver results for Jamaica and attendees, she said, “The format of the conference is powerful, because it presents an excellent opportunity for global business leaders to get valuable insight on Jamaican investment opportunities, engage their colleagues in various industries, and explore bankable projects, all in the location of their choice. We believe that this conference will lead to the development of lucrative partnerships and financial opportunities for local and international investors. ”
Persons can register for the event at explore.dobusinessjamaica.com
ABOUT THE EXPLORE: DO BUSINESS JAMAICA VIRTUAL INVESTMENT CONFERENCE (DBJVIC)
Explore: Do Business Jamaica Virtual Investment Conference is a 2-day event that will highlight investment and other business opportunities in Jamaica. The event, hosted by Jamaica’s investment and export promotion agency, JAMPRO, will provide a platform for attendees to learn more about Jamaican investment opportunities, see lucrative projects, and build business relationships.
Explore Do Business Jamaica Virtual Investment Conference is sponsored by the Foundations for Competitiveness and Growth Project (FCGP), National Commercial Bank (NCB), Mystique Integrated, and M-One Productions
For more information on the conference, please visit https://explore.dobusinessjamaica.com/ .
Follow JAMPRO on:
Twitter
Facebook
Instagram
LinkedIn
View source version on businesswire.com: https://www.businesswire.com/news/home/20210930005861/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FDA Issues Modified Risk Tobacco Product Orders for 20 ZYN Nicotine Pouch Products30.6.2026 18:19:00 CEST | Press release
FDA’s decision makes ZYN the first nicotine pouch product to receive MRTP orders authorizing reduced-risk claims versus cigarettes Philip Morris International Inc. (PMI) (NYSE: PM) today announced that the U.S. Food and Drug Administration (FDA) issued Modified Risk Tobacco Product (MRTP) orders for 20 variants of ZYN nicotine pouch products. These are the first MRTP orders granted for nicotine pouches, allowing PMI U.S. to market the following claim for the authorized ZYN products: “Using ZYN instead of cigarettes puts you at a lower risk of mouth cancer, heart disease, lung cancer, stroke, emphysema, and chronic bronchitis.” “FDA’s decision is an important moment for the more than 45 million legal-age nicotine consumers in America,” saidStacey Kennedy, PMI U.S. CEO. “Today’s news ensures these adultshave access to accurate, science-based information, including FDA-authorized evidence that switching from cigarettes to ZYN reduces the risk of smoking-related diseases like heart disease
Caidya Announces Strategic Combination with Simbec-Orion Bridging Early Scientific Insight and Global Clinical Execution30.6.2026 17:00:00 CEST | Press release
Caidya today announced a strategic combination with Simbec-Orion designed to close the divide between early scientific insight and global clinical execution. The combination of Caidya and Simbec-Orion creates a differentiated specialty clinical CRO platform that enables programs to scale, maintaining focus, speed, and accountability. The strategic combination brings together complementary strengths to create a more complete development partner for innovative biopharma companies. With established operations across Europe, the Americas, APAC, and China, the combined organization provides meaningful expertise and execution capabilities in the regions that matter most. Simbec-Orion brings early-phase clinical pharmacology capabilities alongside deep therapeutic expertise for later stage complex oncology and rare disease trials, helping sponsors shape critical decisions early in the development lifecycle. Together, the organizations strengthen their ability to support complex, cross-border
Archer® Proves Purpose-Built AI Beats General-Purpose LLMs on Regulatory Change Management: 95% Verified Accuracy, 80x Faster, 92% Lower Cost30.6.2026 16:13:00 CEST | Press release
In a head-to-head benchmark, a leading general-purpose LLM was confidently wrong 35% of the time on regulatory dates. Archer Evolv™ shipped zero errors. For enterprises deploying AI in compliance, a wrong date is a missed deadline. The more dangerous failure is a wrong answer the model returns with high confidence, one that flows silently into a compliance calendar and is only discovered after the window has passed. Archer® today released results showing purpose-built AI beats a general-purpose large language model (LLM) on regulatory work, and it’s not close. This head-to-head test compared Archer’s purpose-built, vertical-specific AI and proprietary data sets against a leading general-purpose LLM, on a core compliance task: determining the publication, effective and comment-close dates of regulatory documents across six jurisdictions. General-purpose models are a genuine breakthrough, and this is no referendum on their quality. The question Archer set out to answer is narrower and mo
Altasciences Supports Key Development Milestone for Steel Therapeutics’ Lead Therapeutic Candidate, Fizurex™30.6.2026 16:08:00 CEST | Press release
Altasciences, a leading drug development organization, today announced a significant milestone in the development of Steel Therapeutics, Inc.’s pivotal toxicology study for its lead product candidate, Fizurex™, for the treatment of anal fissures. The successful completion of the study plays a significant role in the advancement of Fizurex™ toward first-in-human trials. The GLP-compliant study demonstrated a favorable safety profile, which has advanced Steel Therapeutics' plans to submit an Investigational New Drug (IND) application for Fizurex™ to the FDA in Q3 2026. Fizurex™, a patent-pending, single-use topical wipe, was designed to provide a standardized, accessible treatment option for a painful and often undertreated medical condition. The product builds on years of use through compounding pharmacy prescriptions and is now advancing toward clinical development and regulatory review. "We are proud to have supported Steel Therapeutics with the generation of the high-quality safety d
Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS30.6.2026 16:00:00 CEST | Press release
IB SmartRouting℠ Routes Orders to the Best Available Price Between KRX and Nextrade Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced the launch of select Korean equities through Nextrade, South Korea's first Alternative Trading System (ATS). The addition of Nextrade builds on Interactive Brokers' earlier launch of the Korea Exchange (KRX), through which it became the first major US-based broker to provide global investors with direct access to Korean equities. Clients trading on Nextrade benefit from significantly extended trading hours and access to additional liquidity. Interactive Brokers has enabled IB SmartRouting℠ across both the Korea Exchange (KRX) and Nextrade, automatically routing orders to the venue offering the best price. This helps clients achieve best execution while providing greater flexibility and more opportunities to participate in one of Asia's most dynamic equity markets. Korea's equity market ranks among the top global exchanges by
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom